-
Reboxetine, sold
under the
brand name
Edronax among others, is a
selective norepinephrine reuptake inhibitor (sNRI)
medication marketed as an antidepressant...
- available. The
first commercially available selective NRI was the drug
reboxetine (Edronax),
developed as a first-line
therapy for
major depressive disorder...
- meta
analysis published in BMJ in 2011
concluded that the
selective NRI
reboxetine is
indistinguishable from
placebo in the
treatment of depression. A second...
- deodorant.
Cinnamyl alcohol is the
starting material used in the
synthesis of
reboxetine.
Cinnamyl alcohol has been
found to have a
sensitizing effect on some...
- following: Vestra, a
village in Vindafjord,
Norway Vestra, a
tradename of
reboxetine Vestra, a
district of Vantaa,
Finland one of the
outposts in the fictional...
- of
reboxetine as an
antidepressant demonstrated attempts to
detect publication bias in
clinical trials.
Based on
positive trial data,
reboxetine was...
- can be
found in
reboxetine where it is
constrained in a
morpholine ring system. Some
studies have been made
where the
oxygen in
reboxetine is
replaced by...
- duloxetine),
norepinephrine reuptake inhibitors (NRIs) (e.g., atomoxetine,
reboxetine), norepinephrine–dopamine
reuptake inhibitors (NDRIs) (e.g., methylphenidate...
-
antidepressants such as mirtazapine, nefazodone, venlafaxine,
duloxetine and
reboxetine. However, this
usage is not universal. This list is not exhaustive, and...
-
Etoperidone (Axiomin, Etonin)
Norepinephrine reuptake inhibitors include:
Reboxetine (Edronax)
Teniloxazine (Lucelan, Metatone) – also a 5-HT2A
receptor antagonist...
